Thermo Fisher Scientific Opens Flagship U.S. Bioprocess Design Center in MA

Thermo Fisher Scientific Inc. has opened its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics.

The new center brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring therapies to patients faster.

The BDC features 4,000 square feet of laboratory and training space to support customers in developing biologics, including vaccines and cell and gene therapies. Customers will experience Thermo Fisher’s complete, end-to-end bioproduction workflow of integrated, scalable solutions, including media, cell line development, single-use systems, chromatography, filtration, purification and analytics.

The strategic addition of the BDC to Thermo Fisher’s 290,000-square-foot Plainville facility introduces bioproduction capabilities that complement its existing integrated sterile fill-finish and viral vector services.

“Our new Bioprocess Design Center brings together Thermo Fisher’s experts and customers to tackle some of the most complex challenges in bioprocessing, demonstrating how collaboration and shared innovation can accelerate therapeutic development and help deliver life-changing therapies to patients faster,” said Daniella Cramp, SVP and President, BioProduction and Customer Excellence at Thermo Fisher Scientific. “By creating a space where customers can work side by side with our scientists and engineers, we can help translate innovative ideas into scalable solutions that advance biologics development and manufacturing for customers across the United States.”